Legal Representation
Attorney
Lisa Martens
USPTO Deadlines
Next Deadline
186 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200804)
Due Date
August 04, 2026
Grace Period Ends
February 04, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 4, 2025 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Dec 12, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Nov 25, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 25, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 4, 2020 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 4, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 19, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 19, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 29, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 13, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 6, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 4, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 3, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 3, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 20, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Nov 19, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Nov 19, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Oct 29, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 27, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Oct 26, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 25, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 24, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Medical, pharmaceutical and veterinary preparations and substances, namely, for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; as well as health care preparations, namely, pharmaceutical preparations for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; medicines for the treatment of diseases associated with the central nervous system; hypoglycemic drugs; medicines for the treatment of antiviral disorders; medicines for the treatment of tumors; cardiovascular treatment preparations; nonsteroidal anti-inflammatory drugs; anti-infectives; chemical preparations for veterinary or pharmaceutical purposes, namely for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders
Class 039
Distribution of products in the field of pharmaceuticals, namely, transportation and delivery of health care preparations in the form of pharmaceutical products, including finished products and semi-finished products for veterinary and cosmetic purposes
Class 042
Pharmaceutical research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; research and development of new pharmaceutical preparations for others; scientific research in the field of pharmacy
Class 044
Medical services, veterinary services; medical consultancy in the field of healthcare and dispensing of pharmaceutical preparations and pharmaceutical consultancy in the field of healthcare and dispensing of pharmaceutical preparations, the aforesaid services also provided via electronic networks, including the internet
Additional Information
Design Mark
The mark consists of the stylized wording "RAYBOW" in green and "PHARMACEUTICAL" in grey, and the design of a rainbow in dark blue, green and light blue.
Color Claim
The color(s) green, grey, light blue and dark blue is/are claimed as a feature of the mark.
Classification
International Classes
005
039
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICAL"